The myth of pulmonary Raynaud's phenomenon: The contribution of pulmonary arterial vasospasm in patients with systemic sclerosis related pulmonary arterial hypertension

Annals of the Rheumatic Diseases

Volumn 63, Issue 12, 2004, Pages 1627-1631

  Mukerjee, D ^a,b   Yap, L B ^b   Ong, V ^b   Denton, C P ^b   Howells, K ^b   Black, C M ^b   Coghlan, J G ^b  

^a BROOMFIELD HOSPITAL   (United Kingdom)

^b ROYAL FREE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

3 NITROTYROSINE; ENDOTHELIN 1; FIBRINOGEN; NITRIC OXIDE; VON WILLEBRAND FACTOR;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COLD EXPOSURE; COLD PRESSOR TEST; CONTROLLED STUDY; ENDOTHELIUM; FEMALE; HEART CATHETERIZATION; HEART OUTPUT; HUMAN; LUNG ARTERY PRESSURE; LUNG VASCULAR RESISTANCE; MALE; PILOT STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; PULMONARY ARTERY; PULMONARY HYPERTENSION; RAYNAUD PHENOMENON; SYSTEMIC SCLEROSIS; THROMBOCYTE FUNCTION; VASOSPASM; WATER IMMERSION;

ADULT; CARDIAC OUTPUT; COLD; ENDOTHELIUM, VASCULAR; FEMALE; HEART CATHETERIZATION; HEMODYNAMIC PROCESSES; HUMANS; HYPERTENSION, PULMONARY; MALE; MIDDLE AGED; PILOT PROJECTS; PROSPECTIVE STUDIES; PULMONARY ARTERY; SCLERODERMA, SYSTEMIC; SPASM; VASCULAR RESISTANCE;

EID: 9644259132     PISSN: 00034967     EISSN: None     Source Type: Journal    
DOI: 10.1136/ard.2003.015289     Document Type: Article

References (31)

1. Rodnan GP, Schumaker HR, eds. Primer on the rheumatic diseases. Atlanta: Arthritis Foundation, 1983:59-65.
2. LeRoy EC, Black CM, Fleischmajer R, Jablonska S, Krieg T, Medsger TA, et al. Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. Br J Rheumatol 1986;15:202-5.
3. Mukerjee D, Coleiro B, Black CM, Coghlan JG. Prevalence and prognostic markers of Scleroderma related pulmonary arterial hypertension. Abstract 2071 Philadelphia: American College of Rheumatology Annual Scientific Meeting, 2001.
4. Yokomushi K. Effects of acute exposure to cold on pulmonary artery blood pressure in awake rats. Nippon Eiseigaku Zasshi 1995;50:616-21.
5. Wise RA, Wigley F, Newball HH, Stevens MB. The effect of cold exposure on diffusing capacity in patients with Raynaud's phenomenon. Chest 1982;81:695-8.
6. Yamauchi K, Suzuki Y, Ichikawa Y, Takaya M, Arimori S. Abnormalities in pulmonary blood flow during cold exposure in SLE. Nucl Med Commun 1988;9:423-30.
7. Ploysongsang Y, Foad BS. Lung function tests in connective tissue diseases associated with Raynaud's phenomenon. Respiration 1984;46:222-30.
8. Vergnon JM, Barthelemy JC, Riffat J, Boissier C, Emonot A. Raynaud's phenomenon of the lungs. A reality both in primary and secondary Raynaud's syndrome. Chest 1992;101:1312-17.
9. Barr WG, Fahey PJ. Reduction of pulmonary capillary blood volume following cold exposure in patients with Raynaud's phenomenon. Chest 1988;94:1195-9.
10. Kozielski J, Ziora D, Dobosz J, Oklek K. Changes in parameters of respiratory function in Raynaud's disease. Pol Arch Meet Wewn 1992;87:341-4.
11. Shuck JW, Oetgen WJ, Tesar JT. Pulmonary vascular response during Raynaud's phenomenon in progressive systemic sclerosis. Am J Med 1985;78:221-7.
12. Aalbers R, Groen H, Postama DS, Van Der Mark TW, Wouda AA, Reig RP, et al. Pulmonary function in patients presenting with Raynaud's phenomenon without an underlying connective tissue disease. A prospective, longitudinal study. J Rheumatol 1989;16:30-41.
13. Williamson DB. Physiological responses to cold exposure in men: a disabled submarine study. Undersea Hyperbaric Med 2002;29:189-203.
14. Giesbrecht GG. The respiratory system in a cold environment. Aviat Space Environ Med 1995;66:890-902.
15. Zubridgge PW. Cold and the airway, Int J Sports Med 1992;13:5182-4.
16. Dziadzio M, Denton CP, Smith R, Howell K, Blann A, Bowers E, et al. Losartan therapy for Raynaud's phenomenon and scleroderma. Arthritis Rheum 1999;42:2646-55.
17. Mayes MD. Endothelin and endothelin receptor antagonists in systemic rheumatic disease. Arthritis Rheum, 2003 May, 48:1190-9.
18. Ter Steege J. The 3-nitrotyrosine assays. Free Radic Biol Med 1998;25:953-63.
19. Rajagopalan S, Pfenninger D, Kehrer C, Chakrabarti A, Somers E, Pavlic R, et al. Increased asymmetric dimethylarginine and endothelin 1 levels in secondary Raynaud's phenomenon: implications for vascular dysfunction and progression of disease. Arthritis Rheum 2003;48:1992-2000.
20. Fraenkel L, Tofler GH, Zhang Y, Silbershatz H, D'Agostino RB, Wilson PW, et al. The associations between plasma levels of von Willebrand factor and fibrinogen with Raynaud's phenomenon in men and women. Am J Med 2000;108:583-6.
21. Herrick AL. Treatment of Raynaud's phenomenon: new insights and developments. Curr Rheumatol Rep 2003;5:168-74.
22. Rich S, Dantzker DR, Ayres SM, Bergofsky EH, Brundage BH, Detre KM, et al. Primary pulmonary hypertension. A national prospective study. Ann Intern Med 1987;107:216-23.
23. MacDonald SL, Rubens MB, Hansell DM, Copley SJ, Desai SR, du Bois RM, et al. Nonspecific interstitial pneumonia and usual interstitial pneumonia: comparative appearances at and diagnostic accuracy of thin-section CT. Radiology 2001;221:600-5.
24. Herrick AL, Illingworth K, Blann A, Hay CR, Hollis S, Jayson MI. Von Willebrand Factor, thrombomodulin, thromboxane, B-thromboglobulin and markers of fibrinolysis in primary Raynaud's phenomenon and systemic sclerosis. Ann Rheum Dis 1996;55:122-7.
25. Gibbs JSR. Recommendations on the management of pulmonary hypertension in clinical practice. British Cardiac Society Guidelines and Medical Practice Committee, and approved by the British Thoracic Society and the British Society of Rheumatology. Heart 2001;86(suppl 1):11-13.
26. Furst DE, Davis JA, Clements PJ, Chopra SK, Theofilopoulos AN, Chia D. Abnormalities of pulmonary vascular dynamics and inflammation in early progressive Systemic Sclerosis. Arthritis Rheum 1981;24:1403-8.
27. Vancheeswaran R, Magoulas T, Efrat G, Wheeler-Jones C, Olsen I, Penny R, et al. Circulating endothelin-1 levels in SSc subsets - a marker of fibrosis or vascular dysfunction? J Rheumatol 1996;21:1838-44.
28. Sakamoto K, Houya I, Inoue K, Tanaka M, Suzuki T, Sakamoto Y, et al. An imbalance in plasma prostanoids in patients with Raynaud's phenomenon and pulmonary vasosposm. Eur Respir J 1999;13:137-44.
29. Zsmora MR, O'Brien RF, Rutherford RB, Weil JV. Serum endothelin 1 concentrations and cold provocation in primary Raynaud's phenomenon. Lancet 1990;336:1144-7.
30. Eliss WW, Baer AN, Robertson RM, Pincus T, Kronenberg MW. Left ventricular dysfunction induced by cold exposure in patients with systemic sclerosis. Am J Med 1986;80:385-92.
31. Cannon P, Hassar M, Case DP, Casarella WJ, Sommers SC, LeRoy EC. The relationship of hypertension and renal failure in scleroderma (progressive systemic sclerosis) to structural and functional abnormalities of the renal cortical circulation. Medicine 1974;53:1-46.